GSK TABLA BEATS
@gsktablabeats • Joined October 31, 2025
Subscribers 2,172 | Views 205,298 | Videos 255
Sub 2.17K | View 205K | Video 255
At a glance
Subscribers
Last 28 days2.17K
+320 (+17.3%)
Views
Last 28 days205K
+26.8K (+15.0%)
Videos
Last 28 days255
+25 (+10.9%)
Charts
Subscribers, views & videos over time
Tap on chart to see values
Loading chart...
Subscribers gained (weekly) · 6 mo
Loading chart...
Views gained (weekly) · 6 mo
Loading chart...
Subs milestone changes (up to 30)
Loading chart...
Views milestone changes (up to 30)
Loading chart...
Engagement
Avg. views per video
805
Total views ÷ total videos
Views per subscriber
95×
Total views ÷ subscribers
Subs per video
9
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $144 – $411
Daily avg.: $1 – $2
Weekly avg.: $5 – $13
Last 28 days: $19 – $54
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:GSK TABLA BEATS
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 1, 2026 Jun 1 Mon | 2.17K +20 | 205K +5.85K | 255 +8 |
May 25, 2026 May 25 Mon | 2.15K +20 | 199K +3.56K | 247 +6 |
May 18, 2026 May 18 Mon | 2.13K +20 | 195K +2.96K | 241 +3 |
May 11, 2026 May 11 Mon | 2.11K +160 | 192K +10.5K | 238 +5 |
May 5, 2026 May 5 Tue | 1.95K +170 | 182K +13.4K | 233 +11 |
Apr 21, 2026 Apr 21 Tue | 1.78K -- | 168K -- | 222 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
Apr 21, 2026 | 10 | -- |
May 5, 2026 | 170 | +160 |
May 11, 2026 | 160 | -10 |
May 18, 2026 | 20 | -140 |
May 25, 2026 | 20 | -- |
Jun 1, 2026 | 20 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
Apr 21, 2026 | 1.65K | -- |
May 5, 2026 | 13.4K | +11.7K |
May 11, 2026 | 10.5K | -2.91K |
May 18, 2026 | 2.96K | -7.56K |
May 25, 2026 | 3.56K | +599 |
Jun 1, 2026 | 5.85K | +2.29K |
About
- Handle
- @gsktablabeats
- Joined
- October 31, 2025
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.